Scan to Download
One power score. Smarter investment decisions
Prelude Therapeutics Inc
PRLD0.985USD
-0.025-2.50%
Close 09/19, 16:00（ET）Quotes delayed by 15 min
USD0.000After-hours (ET)
55.73MMarket Cap
LossP/E TTM
Prelude Therapeutics Inc
0.985
-0.025-2.50%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q3
FY2019Q4
FY2019Q3
Total revenue
----
----
--4.00M
--3.00M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Revenue
----
----
--4.00M
--3.00M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Operating expenses
-13.37%32.19M
0.77%34.61M
1.21%37.83M
11.95%37.38M
14.71%37.16M
17.96%34.34M
11.96%37.38M
9.80%33.38M
9.97%32.40M
-3.87%29.11M
1.14%33.38M
-1.39%30.41M
5.51%29.46M
37.88%30.29M
69.75%33.01M
69.95%30.84M
--27.92M
--21.97M
92.63%19.45M
163.57%18.14M
--10.10M
--6.88M
R&D expenses
-12.62%25.78M
5.13%28.82M
4.25%31.62M
12.17%29.46M
18.20%29.51M
25.53%27.41M
17.25%30.33M
14.73%26.26M
17.16%24.97M
-4.32%21.83M
2.74%25.87M
0.74%22.89M
-4.90%21.31M
38.56%22.82M
72.78%25.18M
48.57%22.72M
--22.41M
--16.47M
64.67%14.57M
178.56%15.29M
--8.85M
--5.49M
Depreciation, depletion, and amortization
-4.20%433.00K
2.11%435.00K
47.73%489.00K
45.16%405.00K
60.85%452.00K
53.24%426.00K
-8.56%331.00K
-17.21%279.00K
-11.64%281.00K
-9.45%278.00K
24.83%362.00K
26.69%337.00K
59.80%318.00K
91.88%307.00K
118.05%290.00K
87.32%266.00K
--199.00K
--160.00K
3.91%133.00K
43.43%142.00K
--128.00K
--99.00K
Operating profit
13.37%-32.19M
-0.77%-34.61M
9.49%-33.83M
-2.97%-34.38M
-14.71%-37.16M
-17.96%-34.34M
-11.96%-37.38M
-9.80%-33.38M
-9.97%-32.40M
3.87%-29.11M
-1.14%-33.38M
1.39%-30.41M
-5.51%-29.46M
-37.88%-30.29M
-69.75%-33.01M
-69.95%-30.84M
---27.92M
---21.97M
-92.63%-19.45M
-163.57%-18.14M
---10.10M
---6.88M
Net non-operating interest income (expenses)
Other non-operating income (expenses)
-60.27%963.00K
-13.43%2.52M
18.49%5.10M
-24.20%2.10M
23.23%2.42M
108.45%2.91M
-9.27%4.30M
519.87%2.78M
-5.75%1.97M
69.74%1.40M
2723.81%4.74M
200.67%448.00K
97.45%2.09M
23.39%823.00K
-14.29%168.00K
-89.23%149.00K
--1.06M
--667.00K
250.00%196.00K
822.67%1.38M
--56.00K
--150.00K
Income before tax
10.10%-31.23M
-2.08%-32.09M
13.13%-28.73M
-5.43%-32.27M
-14.16%-34.74M
-13.40%-31.43M
-15.48%-33.08M
-2.17%-30.61M
-11.17%-30.43M
5.93%-27.72M
12.79%-28.64M
2.38%-29.96M
-1.89%-27.37M
-38.33%-29.46M
-70.61%-32.84M
-83.10%-30.69M
---26.86M
---21.30M
-91.75%-19.25M
-148.89%-16.76M
---10.04M
---6.73M
Income after tax
10.10%-31.23M
-2.08%-32.09M
13.13%-28.73M
-5.43%-32.27M
-14.16%-34.74M
-13.40%-31.43M
-15.48%-33.08M
-2.17%-30.61M
-11.17%-30.43M
5.93%-27.72M
12.79%-28.64M
2.38%-29.96M
-1.89%-27.37M
-38.33%-29.46M
-70.61%-32.84M
-83.10%-30.69M
---26.86M
---21.30M
-91.75%-19.25M
-148.89%-16.76M
---10.04M
---6.73M
Net income from continuous operations
10.10%-31.23M
-2.08%-32.09M
13.13%-28.73M
-5.43%-32.27M
-14.16%-34.74M
-13.40%-31.43M
-15.48%-33.08M
-2.17%-30.61M
-11.17%-30.43M
5.93%-27.72M
12.79%-28.64M
2.38%-29.96M
-1.89%-27.37M
-38.33%-29.46M
-70.61%-32.84M
-83.10%-30.69M
---26.86M
---21.30M
-91.75%-19.25M
-148.89%-16.76M
---10.04M
---6.73M
Net income attributable to controlling interests
10.10%-31.23M
-2.08%-32.09M
13.13%-28.73M
-5.43%-32.27M
-14.16%-34.74M
-13.40%-31.43M
-15.48%-33.08M
-2.17%-30.61M
-11.17%-30.43M
5.93%-27.72M
12.79%-28.64M
2.38%-29.96M
-1.89%-27.37M
-38.33%-29.46M
-70.61%-32.84M
-83.10%-30.69M
---26.86M
---21.30M
-91.75%-19.25M
-148.89%-16.76M
---10.04M
---6.73M
Net income attributable to common shareholders
10.10%-31.23M
-2.08%-32.09M
13.13%-28.73M
-5.43%-32.27M
-14.16%-34.74M
-13.40%-31.43M
-15.48%-33.08M
-2.17%-30.61M
-11.17%-30.43M
5.93%-27.72M
12.79%-28.64M
2.38%-29.96M
-1.89%-27.37M
-38.33%-29.46M
-70.61%-32.84M
-83.10%-30.69M
---26.86M
---21.30M
-91.75%-19.25M
-148.89%-16.76M
---10.04M
---6.73M
Basic earnings per share
10.37%-0.41
-1.74%-0.42
20.32%-0.38
5.99%-0.43
15.26%-0.46
28.53%-0.42
20.86%-0.48
28.33%-0.45
6.55%-0.54
7.25%-0.58
17.33%-0.60
4.68%-0.63
0.73%-0.58
-35.37%-0.63
-40.02%-0.73
83.12%-0.66
---0.58
---0.46
77.93%-0.52
-148.89%-3.92
---2.35
---1.58
Diluted earnings per share
10.37%-0.41
-1.74%-0.42
20.32%-0.38
5.99%-0.43
15.26%-0.46
28.53%-0.42
20.86%-0.48
28.33%-0.45
6.55%-0.54
7.25%-0.58
17.33%-0.60
4.68%-0.63
0.73%-0.58
-35.37%-0.63
-40.02%-0.73
83.12%-0.66
---0.58
---0.46
77.93%-0.52
-148.89%-3.92
---2.35
---1.58
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
